Hepatitis E virus and chronic hepatitis in organ-transplant recipients

New England Journal of Medicine

Volumn 358, Issue 8, 2008, Pages 811-817

  Kamar, Nassim ^a,b   Selves, Janick ^c   Mansuy, Jean Michel ^c   Ouezzani, Leila ^a   Péron, Jean Marie ^b,c   Guitard, Joëlle ^a   Cointault, Olivier ^a   Esposito, Laure ^a   Abravanel, Florence ^c   Danjoux, Marie ^c   Durand, Dominique ^a   Vinel, Jean Pierre ^c   Izopet, Jacques ^c   Rostaing, Lionel ^a,c  

^a Centre Hospitalier Universitaire   (France)

^b CHU RANGUEIL   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD2 ANTIGEN; CD3 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CD4+ T LYMPHOCYTE; CHRONIC HEPATITIS; CLINICAL ARTICLE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; LIVER BIOPSY; LIVER FUNCTION; LYMPHOCYTE COUNT; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 39549089297     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0706992     Document Type: Article

References (24)

1. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003;9:448-54.
2. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002;40:117-22.
3. Ibarra H, Riedemann S, Reinhardt G, Ardiles L, Calvo M, Siegel F. Anti-HEV in dialysis and renal transplant patients in an endemic region in Chile. Clin Nephrol 1998;50:267-8.
4. Buffet C, Laurent-Puig P, Chandot S, et al. A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations. J Hepatol 1996;24:122-5.
5. Sinha S, Jha R, Lakhtakia S, Narayan G. Acute pancreatitis following kidney transplantation - role of viral infections. Clin Transplant 2003;17:32-6.
6. Kamar N, Mansuy JM, Esposito L, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal-allograft recipient. Am J Kidney Dis 2005;45:193-6.
7. Péron JM, Mansuy JM, Récher C, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006;21:1223-4.
8. Mechnik L, Bergman N, Attali M, et al. Acute hepatitis E virus infection presenting as a prolonged cholestatic jaundice. J Clin Gastroenterol 2001;33:421-2.
9. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-20.
10. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003;13:145-54.
11. Mansuy JM, Peron JM, Bureau C, Alric L, Vinel JP, Izopet J. Immunologically silent autochthonous acute hepatitis E virus infection in France. J Clin Microbiol 2004;42:912-3.
12. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
13. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004;85:240-4.
14. Péron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007;14:298-303.
15. Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419-24.
16. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;859-60.
17. Péron JM, Mansuy JM, Poirson H, et al. Hepatitis E is an autochthonous disease in industrialized countries: analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol 2006;30:757-62.
18. Peron JM, Danjoux M, Kamar N, et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France. Virchows Arch 2007;450:405-10.
19. Rentenaar RJ, van Diepen FN, Meijer RT, et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 2002;62:319-28.
20. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 1992;53:1071-6.
21. Aagaard-Tillery KM, Jelinek DF. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 1994;156:493-507.
22. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that the antibody to hepatitis E virus protects against disease. J Infect Dis 1994;170:517-21.
23. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994;91:10198-202.
24. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.